Functions of Epithelial Splicing Regulatory Proteins and their role in the EMT
Functions of Epithelial Splicing Regulatory Proteins and their role in the EMT
批准号:
8086050
负责人:
RUSS Paul CARSTENS
金额:
$15.83万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-02 至 2011-06-30
关键词:
Alternative SplicingBindingBinding SitesBiological AssayCD44 geneCell LineCellsComplementary DNAComplexDeletion MutationDevelopmentDiseaseDown-RegulationEctopic ExpressionEnsureEpithelialEpithelial CellsEventExonsFGFR2 geneGene ExpressionGenesHomeostasisLuciferasesMaintenanceMalignant NeoplasmsMediatingMesenchymalModelingMolecularMutation AnalysisNamesNeoplasm MetastasisOrganParacrine CommunicationPathway interactionsPatternPhenotypeProcessProtein Binding DomainProtein IsoformsProteinsRNARNA BindingRNA InterferenceRNA Recognition MotifRNA SplicingRegulationRoleSignal PathwaySiteTertiary Protein StructureTranscriptVariantbasecDNA Expressioncell growthcell typeepithelial to mesenchymal transitiongain of functiongenetic regulatory proteingenome-widehigh throughput screeningloss of functionnoveloverexpressionparalogous geneprogramsprotein protein interactionrestorationsmall moleculetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Alternative splicing of FGFR2 exons IIIb and IIIc results in the cell type-specific expression of the
FGFR2-IIIb isoform in epithelial cells and FGFR2-IIIc in mesenchymal cells and this splicing choice is essential
during development. We previously hypothesized an epithelial cell-type specific splicing program in which
FGFR2 and other transcripts is coordinated by epithelial-specific splicing regulators. In the first successful use
of a genome-wide, high throughput cDNA expression screen for splicing factors, we discovered essential
epithelial-specific FGFR2 splicing regulators and named them Epithelial Splicing Regulatory Proteins 1 and 2
(ESRP1 and ESRP2). Ectopic expression of either protein in mesenchymal cells switches FGFR2 splicing to
the epithelial pattern, whereas depletion of both factors in epithelial cells via RNA interference has the opposite
effect. Further identification of CD44, ENAH, and p120-ctn as splicing targets of ESRP1 and ESRP2
implicates these proteins as the regulators of a broader epithelial post-transcriptional gene expression
program. We will further characterize the mechanisms by which the ESRPs regulate splicing of FGFR2 and
identify additional co-regulated alternatively spliced transcripts that constitute an epithelial-specific splicing
signature. Expression of both ESRP1 and ESRP2 is turned off during the Epithelial Mesenchymal Transition
(EMT) and therefore we will also investigate the role of ESRP downregulation and the corresponding changes
in splicing of co-regulated transcripts that contribute to the EMT.
Specific Aim Number 1. Complete the identification of FGFR2 splicing regulators using
established high throughput, cell-based splicing assays. We will complete genome-wide, high-throughput
screens to establish a comprehensive set of splicing regulators that cooperate with the ESRPs in the general
epithelial splicing program.
Specific Aim Number 2. Investigate the mechanisms by which ESRP1 and ESRP2 regulate
epithelial cell type-specific splicing. The molecular mechanisms by which the ESRPs regulate splicing will
be investigated through the identification of ESRP binding sites, essential protein domains, and functionally
relevant protein-protein interactions.
Specific Aim Number 3. Identify an epithelial cell type-specific splicing signature of co-
regulated alternative splicing events that are regulated by the ESRPs. Using splicing sensitive
microarrays we will define a comprehensive set of biologically coherent transcripts that are co-regulated by the
ESRPs in addition to FGFR2, CD44, ENAH, and p120-Ctn.
Specific Aim Number 4. Investigate the role of the ESRPs in the Epithelial Mesenchymal
Transition (EMT). We will determine whether the loss of ESRPs expression is required for the EMT to occur
and whether ESRP expression sufficient to induce a Mesenchymal to Epithelial Transition (MET).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Esrp regulated programs of alternative splicing in skin development and function
-
批准号:9058997
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2015
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Roles of Epithelial Splicing Regulatory Proteins in craniofacial development
-
批准号:9267966
-
项目类别:
-
资助金额:$58.01万
-
财政年份:2015
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Roles of Epithelial Splicing Regulatory Proteins in craniofacial development
-
批准号:8800527
-
项目类别:
-
资助金额:$48.04万
-
财政年份:2015
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Esrp regulated programs of alternative splicing in skin development and function
-
批准号:8899793
-
项目类别:
-
资助金额:$36.97万
-
财政年份:2014
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Roles of Epithelial Splicing Regulatory Proteins in craniofacial development
-
批准号:8915301
-
项目类别:
-
资助金额:$46.16万
-
财政年份:2014
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Comprehensive determination of the human proteins that define the splicing code
-
批准号:8350934
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2012
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Global programs of ESRP-regulated splicing in renal development and function
-
批准号:8545244
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2012
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Comprehensive determination of the human proteins that define the splicing code
-
批准号:8513387
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:RUSS Paul CARSTENS
-
依托单位:
High throughput assays for modulators of splicing switches during the EMT
-
批准号:8181147
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2011
-
负责人:RUSS Paul CARSTENS
-
依托单位:
RNA Targets of the Wilm's Tumor Protein in the Kidney
-
批准号:6779511
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2004
-
负责人:RUSS Paul CARSTENS
-
依托单位:
RNA Targets of the Wilm's Tumor Protein in the Kidney
-
批准号:6868166
-
项目类别:
-
资助金额:$15.85万
-
财政年份:2004
-
负责人:RUSS Paul CARSTENS
-
依托单位:
REGULATION OF FGF RECEPTOR SPLICING IN PROSTATE CANCER
-
批准号:6617715
-
项目类别:
-
资助金额:$26.91万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
REGULATION OF FGF RECEPTOR SPLICING IN PROSTATE CANCER
-
批准号:6735727
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
REGULATION OF FGF RECEPTOR SPLICING IN PROSTATE CANCER
-
批准号:7061280
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Functions of Epithelial Splicing Regulatory Proteins and their role in the EMT
-
批准号:7729712
-
项目类别:
-
资助金额:$31.17万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Functions of Epithelial Splicing Regulatory Proteins and their role in the EMT
-
批准号:7883227
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Functions of Epithelial Splicing Regulatory Proteins and their role in the EMT
-
批准号:8097295
-
项目类别:
-
资助金额:$31.05万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
REGULATION OF FGF RECEPTOR SPLICING IN PROSTATE CANCER
-
批准号:6887740
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
REGULATION OF FGF RECEPTOR SPLICING IN PROSTATE CANCER
-
批准号:7229057
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
Functions of Epithelial Splicing Regulatory Proteins and their role in the EMT
-
批准号:8691266
-
项目类别:
-
资助金额:$10.45万
-
财政年份:2003
-
负责人:RUSS Paul CARSTENS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: